Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
41.71
-0.89 (-2.09%)
Dec 5, 2025, 4:00 PM EST - Market closed
Maze Therapeutics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Maze Therapeutics stock ranges from a low of $28 to a high of $60. The average analyst price target of $41 forecasts a -1.70% decrease in the stock price over the next year.
Price Target: $41.00 (-1.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +31.86% | Dec 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +43.85% | Dec 3, 2025 |
| Wedbush | Wedbush | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | -13.69% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $27 → $37 | Buy | Maintains | $27 → $37 | -11.29% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +19.88% | Sep 18, 2025 |
Financial Forecast
Revenue This Year
n/a
from 167.50M
Revenue Next Year
1.53M
EPS This Year
-3.27
from 1.25
EPS Next Year
-3.15
from -3.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 12.6M | ||||
| Avg | n/a | 1.5M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.21 | -2.71 | ||||
| Avg | -3.27 | -3.15 | ||||
| Low | -3.38 | -3.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.